FDA approves Pfizer’s RSV vaccine for use in pregnancy

The Food and Drug Administration on Monday approved a vaccine to prevent respiratory syncytial virus infections in infants during their first few months of life, giving an OK to Pfizer’s shot Abrysvo for use during pregnancy.